• Explore /
  • Poster
  • / Prostate-specific membrane antigen PET response associates with radiographic progression-free survival following stereotactic ablative radiation therapy in oligometastatic castration-sensitive prostate cancer.

Prostate-specific membrane antigen PET response associates with radiographic progression-free survival following stereotactic ablative radiation therapy in oligometastatic castration-sensitive prostate cancer.

Abstract Poster

Authors

null

Philip Sutera

Johns Hopkins University, Baltimore, MD

Philip Sutera , Matthew Deek , Ozan Cem Guler , Pervin Hurmuz , Mehmet Reyhan , Steven P. Rowe , William Hrinivich , Lei Ren , Ana Ponce Kiess , Daniel Y. Song , Ezgi Oymak , Kenneth J. Pienta , Martin Pomper , Felix Y Feng , Gokhan Ozyigit , Phuoc T. Tran , Ryan Phillips , Huseyin Cem Onal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Epidemiology/Outcomes

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 5011)

DOI

10.1200/JCO.2022.40.16_suppl.5011

Abstract #

5011

Poster Bd #

195

Abstract Disclosures

Similar Posters

First Author: Alberto Carretero-González

First Author: Corbin J. Eule

First Author: Carissa Chu

First Author: Phuoc T. Tran